CHASTACEY BOWERS: Open Payments
NPI 1437877248 · COMPTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 17 payments from 8 companies in 2025. Trend: 2023 $1,308 · 2024 $2,841 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $214 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Janssen Pharmaceuticals, Inc | 3 | $93 |
| ABBVIE INC. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $36 |
| Lundbeck LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: LYBALVI, COBENFY, INVEGA SUSTENNA, ARISTADA, VRAYLAR, REXULTI, INGREZZA, CAPLYTA.
Industry payments across CA — which companies pay providers there.
